, were tested for agonistic activity as well as for their ability to antagonize the myotropic actions of NKB, neurokinin A, substance P, physalaemin and eledoisin in isolated guinea-pig ileum, guinea-pig urinary bladder, rat duode num, rat vas deferens and rat portal vein.
A decapeptide amide neurokinin B (NKB) (1, 2) [H-Asp-Met-His-Asp-Phe-Phe-Val Gly-Leu-Met-NH2] belongs to a family of tachykinins such as neurokinin A, substance P, eledoisin and physalaemin, which share the common C-terminal sequence Phe-X Gly-Leu-Met-NH2, and it potently contracts smooth muscle preparations.
Our study (3) on NKB [3] [4] [5] [6] [7] [8] [9] [10] [H-His-Asp Phe-Phe-Val-Gly-Leu-Met-NH2] suggests that the amino acid residues at positions 4, 5, 6 and 7 of the NKB molecule may be respon sible for tachykinin receptors, which have been subdivided into SP-P, SP-E and SP-K types in the smooth muscles of mammals by Buck et al. (4) , Lee et al. (5) and Laufer et al. (6) . Furthermore, NKB related octapeptides analogs, [GIy6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] [H-His-Asp Phe-Gly-Val-Gly-Leu- Met-NH2] and [Arg3, D-Ala6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] [H-Arg-Asp-Phe-D Ala-Val-Gly-Leu-Met NH2], were found to be fairly potent antagonists against NKB in the isolated guinea-pig ileum, but not against substance P and neurokinin A (7) .
In the present study, we investigated the contractile activities of NKB analogs and their ability to antagonize the myotropic actions of NKB, neurokinin A, substance P, physalaemin and eledoisin in five smooth muscle pre parations.
Biological properties of the synthetic peptides were examined in isolated SP-P type (guinea-pig ileum and guinea-pig urinary bladder) (5), SP-E type (rat duodenum and rat vas deferens) (5) and SP-K type (rat portal vein) tissues (4, 6) . Male or female guinea-pigs (weighing 200-250 g) and male rats (weighing 250-300 g) were killed by bleeding from the neck. The desired organs were taken out rapidly. Longitudinal strips (about 20 mm) were removed from guinea pig ileum and rat duodenum. The rat portal vein was cut helically (about 1 x 15-20 mm), and the guinea-pig urinary bladder was cut vertically (about 1 x 10 mm). Each preparation was suspended in a 10 ml organ bath con taining Tyrode's solution gassed with a mixture of 95%02 and 5% CO2 and kept at 30°C. The muscle preparations were equili brated for 60 min under a load of 1-2 g and washed every 20 min. Responses to peptides were recorded using an isotonic transducer (TD-111T, Nihon Kohden) on a Servocorder (Watanabe Instruments, SR 6204). The bathing fluid had the following composition (mM): NaCI, 137; KCI, 2.7; CaCI2, 1.8; MgCl2, 1.1 ; NaH2PO4, 0.4; NaHCO3, 12; and glucose, 5.6.
Concentration-response curves of NKB, substance P, neurokinin A, eledoisin, physal aemin and NKB analogs were obtained cumu latively (50-100 ,ul volumes per each ap plication), in order to estimate the apparent affinities of agonists and maximum responses. However, the contractile effects of substance P and physalaemin were not measured in rat vas deferens since the agonists are practically inactive in this preparation.
The contractile effects of the NKB analogs were evaluated by measuring consecutive injections of each stimulant at intervals of 10-15 min. All the peptides were applied up to the concen tration of 10-6 M to test their agonistic activities. The antagonistic effects of the NKB analogs were assessed from the analysis of the cumulative dose-response curves with three concentrations (2x`10-6 M, 5 x 10-6 M and 10-5 M) of the NKB analogs in the bath [added 10 min before an application of tachykinin peptide (8)]. The pharmacological parameters of a (an intrinsic activity), pA2 (the negative log of the dissociation constant of an antagonist) and Schild plot (9, 10) were used to characterize the NKB analogs.
[Gly6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] and [Arg3, D-Ala6] NKB [3] [4] [5] [6] [7] [8] [9] [10] were synthesized and purified in our laboratory, and the procedures were reported elsewhere (3, 7) . Other peptides used in this study were synthesized by the same method as employed for the prep aration of NKB related peptides on a Beckman System 990C Peptide Synthesizer by the standard solid phase method in our laboratory. The synthetic products were sub jected to preparative reverse-phase high performance liquid chromatography as re ported previously (3) using a column of Chemcosorb ODS (Chemco, 20x300 mm) with 0.1% trifluoroacetic acid in acetonitrile as eluent. Highly purified peptides were obtained after gel filtration on a Sephadex LH 20 column. Purity of the peptides was monitored by analytical high performance liquid chromatography on a column of NOVA-PAK C18 (3.9 x 150 mm) with gradi ent elution using 20 mM phosphate buffer (pH 3.0)/acetonitrile. Amino acid analyses on samples previously hydrolyzed with 6 N HCI (110°C, 24 hr) were performed on a Beckman System 7300 Amino Acid Analyzer. Acid hydrolysates of the peptides contained the constituent amino acids in the ratios predicted by theory.
The contractile activities of [GIy6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] and [Arg3, D-Ala6] -NKB [3] [4] [5] [6] [7] [8] [9] [10] were tested in the five smooth muscle preparations described above. Both NKB analogs exerted no agonistic activities in the guinea-pig urinary bladder, rat duodenum, rat vas deferens and rat portal vein. However, in the guinea-pig ileum preparation, the values of a for [GIy6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] and [Arg3, D-Ala6] NKB [3] [4] [5] [6] [7] [8] [9] [10] were 0.1 and less than 0.1 (Table 1) , respectively. Therefore, effects of both the peptides on contractile responses of five tissues to five tachykinin peptides were tested.
[GIy6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] parallelly shifted the concentration-response curve of NKB in the guinea-pig ileum and rat portal vein pre parations towards higher concentrations, sug gesting competitive antagonism (Fig. 1 , the results in rat portal vein preparation). The pA2 values in guinea-pig ileum and rat portal vein were 5.81 ±0.04 and 5.60±0.05, respec Fig. 1. (mean±S.E.) .
The slope was not significantly different from unity. ND: [Arg3, o-Alas]-NKB [3] [4] [5] [6] [7] [8] [9] [10] failed to antagonize the response to NKB in rat portal vein.
tively. However, no antagonistic effects of [Gly6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] against five tachykinin peptides were observed in guinea-pig urinary bladder, rat duodenum, or rat vas deferens preparation.
[Arg3, D-Ala6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] also caused a parallel shift of the concentration response curve for NKB to the right in the guinea-pig ileum preparation, in a concen tration-dependent manner, and the pA2 value was 5.67±0.04.
[Arg3, D-Ala6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] failed to antagonize the response to any tachykinin peptide in guinea-pig urinary bladder, rat duodenum, rat vas deferens and rat portal vein preparations.
Each slope (Table 1) of the Schild plot calculated from the results of experiments with three con centrations of each of the NKB antagonists was close to unity, also suggesting a com petitive antagonism.
[GIy6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] acted as an antagonist against NKB in the guinea-pig ileum and rat portal vein preparations, but not against substance P. neurokinin A, eledoisin or physalaemin.
No antagonistic activity of [Gly6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] against NKB, substance P, neurokinin A, eledoisin or physalaemin was observed in guinea-pig urinary bladder, rat duodenum, or rat vas deferens preparation. I n other words, the replacement of Phe at position 6 on NKB [3] [4] [5] [6] [7] [8] [9] [10] with Gly changed the pharmacological spectrum of NKB from that of an agonist to that of an antagonist in guinea-pig ileum and rat portal vein tissues, but not in guinea-pig urinary bladder, rat duodenum or rat vas deferens preparation.
[Arg3, D-Ala6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] exerted an antagonistic effect against NKB among the five tachykinin peptides in the guinea-pig ileum preparation, and no antagonistic ac tivity against tachykinin peptides was ob served in guinea-pig urinary bladder, rat duodenum, rat vas deferens, or rat portal vein preparation. The present data revealed some important differences between smooth muscle preparations containing SP-P receptor, which showed significant differences in their sensi tivity to the antagonists.
[GIy6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] and [Arg3, D-Ala6]-NKB [3] [4] [5] [6] [7] [8] [9] [10] exhibited an antagonistic effect against NKB in the guinea-pig ileum preparation, but not in guinea-pig urinary bladder preparation. Simi larly, in the preparations containing SP-E type receptor, Regoli et al. (11) reported that a tachykinin antagonist [D-Pro4, D-Trp7's,10 Phe"]-substance P [4] [5] [6] [7] [8] [9] [10] [11] was inactive in hamster urinary bladder preparation, but active in rat duodenum preparation. So further study using a potent and specific agonist and antagonist will be needed in order to obtain information regarding the possible multiplicity of receptors for tachy kinin peptides.
NKB has the most structural homology with neurokinin A [H -His Lys-Thr-Asp-Ser Phe-Val-Gly Leu-Met-NH2] among tachy kinin peptides. NKB shares six amino acid residues with neurokinin A: the four amino acid residues at positions 1, 2, 3 and 5 between the sequences of NKB and neuro kinin A are different from each other. The present results suggest that the mammalian tachykinin receptor subtypes in the guinea pig ileum and the rat portal vein tissues may be able to recognize the difference between the four amino acid residues at positions 1, [3] [4] [5] [6] [7] [8] [9] [10] were found to act as fairly potent NKB specific, competitive and tissue selective antagonists.
